Skip to main content
main-content

Type 2 diabetes

News

10-18-2018 | Empagliflozin | News

Up to 4.5 years’ life gained with SGTL2 inhibition in EMPA REG

The protective effect of empagliflozin against cardiovascular and all-cause mortality translates into between 1.0 and 4.5 years of additional life expectancy for high-risk patients with type 2 diabetes, say the EMPA REG OUTCOME investigators.

10-17-2018 | Liraglutide (T2DM) | News

Cardiovascular benefits of liraglutide in type 2 diabetes apply to high-risk subgroups

The cardioprotective effects of liraglutide apply to patients with chronic kidney disease as well as those with established cardiovascular disease, show two post-hoc analyses of the LEADER trial.

10-16-2018 | Metabolic surgery | medwireNews | News

Marked reduction in vascular events in diabetes patients after bariatric surgery

An observational study published in JAMA demonstrates a substantial reduction in the risk for hard cardiovascular endpoints in obese patients with type 2 diabetes who have undergone bariatric surgery.

Read more

Opinion

09-12-2018 | Diet | Commentary | Article

Diet–drug interactions: Why two rights can make a wrong

Editorial Board member and Endocrinologist, Sanjay Kalra comments on the issues raised by a clinical case involving sodium glucose cotransporter 2 inhibitor therapy alongside a restrictive diet.

08-22-2018 | Psychosocial care | Editorial | Article

Shared decision-making in patient-centered care

Is the medical model of care failing diabetes patients in its current form? Advisory Board member Katharine Barnard considers this, and the future of clinical decision support.

08-15-2018 | Neuropathy | Editorial | Article

Are we using the right tests to diagnose diabetic neuropathy?

Uazman Alam and colleagues interrogate current evidence and real-world clinical scenarios to address whether enough is being done with the tools available to screen and diagnose diabetic neuropathy.

In depth

09-30-2018 | UKPDS | Feature | Article

The UKPDS: A lasting legacy

Twenty years after the publication of the primary findings, medwireNews talks to longtime UKPDS investigator Professor David Matthews (University of Oxford, UK) about the struggles of the team to bring the trial to completion and the impact of the findings on diabetes care.

03-27-2018 | Inpatient diabetes | Feature | Article

The inpatient diabetes audit: A tool for change

With the 2017 NaDIA results showing some positive trends in inpatient diabetes care, medwireNews talks to national clinical lead Gerry Rayman about the tools and tactics to deliver the best patient outcomes.

Original research

Journal articles and book chapters

10-15-2018 | Statins | Review | Article

Beyond statins: Who and when to prescribe?

Ganda O. Curr Diab Rep 2018; 18: 126. doi: 10.1007/s11892-018-1087-0

10-04-2018 | Mobile technology | Review | Article

App-based insulin calculators: Current and future state

Eiland L et al. Curr Diab Rep 2018; 18: 123. doi: 10.1007/s11892-018-1097-y

09-13-2018 | Pathophysiology | Review | Article

Altered gut microbiota in type 2 diabetes: Just a coincidence?

Sircana A et al. Curr Diab Rep 2018; 18: 98. doi: 10.1007/s11892-018-1057-6

In practice

06-01-2017 | Type 2 diabetes | Review | Article

Practical recommendations for transitioning patients with type 2 diabetes from hospital to home

Donihi AC. Curr Diab Rep 2017; 17: 52. doi: 10.1007/s11892-017-0876-1

04-04-2017 | Screening | Article

Understanding type 2 diabetes mellitus screening practices among primary care physicians: A qualitative chart-stimulated recall study

Hafez D et al. BMC Fam Pract 2017; 18: 50. doi: 10.1186/s12875-017-0623-3

02-16-2017 | Type 2 diabetes | In practice | Article

The role of the pharmacist in managing type 2 diabetes with glucagon-like peptide-1 receptor agonists as add-on therapy

Meece J. Adv Ther 2017; 34: 638–657. doi: 10.1007/s12325-017-0491-1

Case reports

05-28-2018 | Lifestyle interventions | Case report | Article

Successful management of poorly controlled type 2 diabetes with multidisciplinary neurobehavioral rehabilitation: A case report and review

Deng Z et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0448-7

03-29-2018 | Pregnancy | Case report | Article

Empagliflozin, metformin, and insulin degludec, during pregnancy: A case report

Formoso G et al. Acta Diabetol 2018; 55: 759. doi: 10.1007/s00592-018-1134-y

12-08-2016 | Hypoglycemia | Case report | Article

Hypoglycemia

Zammitt NN, Frier BM. In: Endocrinology and Diabetes. Edited by Ajjan R, Orme S. Springer, London, 2015. doi: 10.1007/978-1-4471-2789-5_17

image credits